Update on pathological platelet activation in coronary thrombosis
- 14 October 2018
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (3) , 2121-2133
Abstract
Although coronary thrombosis (CT) is integral to cardiovascular outcomes, the underlying pathophysiological mechanisms remain unclear. CT may occur in case of atherosclerotic plaque erosion/rupture, or even after stenting implantation. Platelets (PLT) activation is the keystone of atherothrombosis and depends on many dysregulated elements, including endothelial dysfunction, oxidized lipoproteins, and immune response. Besides the classical view of PLT as an effector of hemostatic response, a new repertoire of PLT activities is emerging. PLT lipidome oxidation is a self‐maintaining process which promotes PLT reactivity, coagulation cascade, and inflammatory cell activation. PLT‐innate immune cell interaction is also sustained by neutrophil extracellular traps and NLRP3 inflammasome pathways. Other noteworthy emerging mechanisms are implicated in the crosstalk between PLT and surrounding cells. Especially, microvesicles (MVs) released from PLT may extend their signaling network far beyond the classical cell−cell interactions. Moreover, the recognition of noncoding RNA in PLT MVs introduce another layer of complexity in terms of intercellular signaling by a direct regulation of messenger RNA profile and gene expression in the recipient cells. The aim of this narrative review is to update the recent advance in CT and intracoronary stent thrombosis, including causal factors and potential translation of experimental evidence into the clinical setting.Keywords
Funding Information
- Ministero della Salute (Rete Cardiologica)
This publication has 91 references indexed in Scilit:
- Uptake of oxLDL and IL-10 Production by Macrophages Requires PAFR and CD36 Recruitment into the Same Lipid RaftsPLOS ONE, 2013
- Gene therapy enters the pharma market: The short story of a long journeyEMBO Molecular Medicine, 2013
- The Repertoire and Features of Human Platelet microRNAsPLOS ONE, 2012
- Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2Circulation, 2012
- Lipopolysaccharide Signaling without a Nucleus: Kinase Cascades Stimulate Platelet Shedding of Proinflammatory IL-1β–Rich MicroparticlesThe Journal of Immunology, 2011
- The Pathology of Neoatherosclerosis in Human Coronary ImplantsJACC, 2011
- Regulation of Platelet Function by Class B Scavenger Receptors in HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Existence of a microRNA pathway in anucleate plateletsNature Structural & Molecular Biology, 2009
- Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activationJournal of Clinical Investigation, 2008
- Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotypeNature Medicine, 2007